Wearable Medical Devices Market
Oct 01, 2025
Wearables 2.0: The Next Wave of Clinical-Grade Wearable Medical Devices
Not long ago, the word wearable instantly brought to mind fitness trackers counting steps or smartwatches nudging users to stand up. While those devices sparked the early boom, the next chapter, Wearables 2.0, is unfolding at the intersection of healthcare and technology. Today, wearable medical devices are no long...
Read More...
May 07, 2025
Artificial Intelligence and Machine Learning in Software as a Medical Device (SaMD)
Artificial Intelligence (AI) and Machine Learning (ML) are reshaping the world of Software as a Medical Device (SaMD), bringing a new level of intelligence and efficiency to healthcare. SaMD refers to software designed for medical purposes that doesn’t rely on physical hardware. When integrated with AI/ML, these so...
Read More...
May 01, 2024
From Wrist to Wellness: The Evolving Landscape of Wearable Medical Devices Market
The healthcare market has witnessed a remarkable transformation in recent years, largely driven by rapid advancements in technology and innovation. Among the most notable developments is the evolution of wearable medical devices, which have transcended their traditional roles to become indispensable tools in the mo...
Read More...
Sep 15, 2022
Aerin Medical’s RhinAer Stylus; CE Mark for Haemonetics’s VASCADE Vascular Closure Device; J&J Vision Launches ACUVUE OASYS MAX 1-Day; Olympus Launches VISERA ELITE III Surgical Visualization Platform; GlucoRx’s Non-Invasive Glucose Monitoring Platform; Medtronic-BioIntelliSense’s Partnership; Corindus’s CorPath GRX Neurovascular System Trial; GE & Lantheus [18F]flurpiridaz PET Radiotracer Trial; Pulmonx’s AeriSeal System Trial; AtriAN’s Second Study on Cardioneuroablation
Johnson & Johnson Vision Launches New Contact Lens Innovation ACUVUE® OASYS MAX 1-Day for Meeting the Needs of Digitally Intense Lifestyles On September 12, 2022, Johnson & Johnson Vision, a part of Johnson & Johnson and a global leader in the eyecare market, had announced the launch of its newest in...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
